Laurindo Pereira de Souza¹*, Plinio Marinho De Carvalho Júnior², Roger Augusto Pereira³, Humberto Müller Martins dos Santos⁴, Maria Izabel Pereira Carneiro⁵ and Marcia Guerino de Lima⁶

¹Eighth Period Medical Student at the Centro Universitário aurício de Nassau de Cacoal - Uninassau Cacoal, Rondônia. Brazil. PhD and Master’s in Health Sciences from the Institute of Medical Assistance to the Public Servant of the State of São Paulo-IAMSPE-São Paulo, Brazil. Specialist Title in Intensive Care Nursing from the Associação Brasileira de Enfermagem em Terapia Intensiva-ABENTI/AMIB, Brazil. Coordinator of the Multiprofessional Residency in Health Commission (COREMU) of the Regional Hospital of Cacoal (HRC), Cacoal, Rondônia, Brazil
²Eighth Period Medical Student at the Centro Universitário Maurício de Nassau de Cacoal - Uninassau Cacoal, Rondônia. Brazil. Master in Pharmaceutical Sciences from the Universidade São Francisco, Bragança Paulista - SP, 2002. Biochemist Pharmacist from the University of São Francisco, Bragança Paulista - SP, 2002. CEO of CIAP EDUCACIONAL-Cacoal, Rondônia, Brazil
³Eighth Period Medical Student at the Centro Universitário Maurício de Nassau de Cacoal - Uninassau Cacoal, Rondônia. Brazil. Physiotherapist from the Universidade do Norte do Paraná-PR, Brazil
⁴Physician Specialist in Psychiatry from the Brazilian Association of Psychiatry and Brazilian Medical Association (ABP/AMB). Specialist in Interventionist Psychiatry (Ipq-HCFMUSP). Professor of Medicine at the University Center Maurício de Nassau of Cacoal - Uninassau Cacoal, Rondônia. Brazil. Master’s in Sciences Applied to Hospital Care (HUJM - UFMT), Brazil
⁵Co-Advisor, Psychologist, Specialist in ABA for Autism, and Intellectual Disability. Applier of the Denver II Developmental Screening Test. Specialist in Early Intervention in Autism. CEO of CIAP EDUCACIONAL-Cacoal, Rondônia, Brazil
⁶Advisor, Specialist in Obstetrics and Social Obstetrics, Specialist in Neonatal and Pediatric ICU. Professor of Medicine at the Centro Universitário Maurício de Nassau de Cacoal - Uninassau Cacoal, Rondônia. Brazil. Specialist in Pediatric and Neonatal ICU. Specialist in Didactics of Higher Education, Brazil

*Corresponding Author: Laurindo Pereira de Souza, Eighth Period Medical Student at the Centro Universitário aurício de Nassau de Cacoal - Uninassau Cacoal, Rondônia. Brazil. PhD and Master’s in Health Sciences from the Institute of Medical Assistance to the Public Servant of the State of São Paulo-IAMSPE-São Paulo, Brazil. Specialist Title in Intensive Care Nursing from the Associação Brasileira de Enfermagem em Terapia Intensiva-ABENTI/AMIB, Brazil. Coordinator of the Multiprofessional Residency in Health Commission (COREMU) of the Regional Hospital of Cacoal (HRC), Cacoal, Rondônia, Brazil.

Received: November 23, 2022; Published: December 07, 2022

Abstract

Introduction: The autistic spectrum disorder (ASD) manifests itself from the earliest age, often before the age of 3 until adulthood. The early diagnosis of the disorder is essential both for families and for people with ASD, as it allows guiding treatments and interventions.

Objective: To map and analyze the scientific literature regarding the impact of early intervention in the treatment of the autistic spectrum from the medical perspective.

Method: This is research of the integrative review type and supported by the adapted PRISMA protocol, in which the online search occurred through the SciELO, Medline/Pubmed, LILACS and Epistemonikos databases, and the temporal cut-off established for the search of the studies was from 2012 to March 2022. Results: The results showed that of the total of 22 of the selected studies, 81.8% were published between 2020 to 2022, showing that the database with the largest scientific collection regarding TEA was sciELO(50%). As most of the studies were Brazilian, the dominant language was Portuguese; however, the studies with more robust designs were published in the United States of America.

Conclusion: It was concluded from the scientific literature that there is no early pharmacological intervention that can treat ASD; these alternatives are only to minimize the clinical picture related to hyperactivity, aggressiveness, and other more severe alterations. What do exist are early behavioral interventions, which are considered the gold standard for symptom control as well as for optimizing the treatment of the person with ASD.

Keywords:Autism Spectrum Disorder; Early Diagnosis; Early Medical Intervention; Autism; Autistic Disorder

References

1. American Psychiatry Association (APA). “Manual diagnóstico e estatístico de transtornos mentais-DSM-V”. Porto Alegre: Artmed (2014).
2. Nascimento IB., et al. “Strategies for autismo spectrum disorder: Social interaction and therapeutic interventions”. Journal Brasileiro de Psiquiatria2 (2021): 179-187.
3. Kodak T., et al. “Management of Children with Autism Spectrum Disorders”. Journal of Bangladesh College of Physicians and Surgeons3 (2020): 16-29.
4. Gadia C. Aprendizagem e autismo. In: Rotta NT., et al. (Org.). “Transtornos da Aprendizagem: abordagem neurobiológica e multidisciplinar”. Porto Alegre (2006).
5. Martins ADF., et al. “Alunos autistas: análise das possibilidades de interação social no contexto pedagógico”. Psicologia Escolar e Educacional2 (2017): 215-224.
6. Pereira da Rosa MI. “Revisão de literatura acerca do transtorno do espectro Autista (TEA) - noções importantes para família e escola”. Evento: XXIII Jornada de Pesquisa. UNIJUÍ (2018).
7. Mello AMRde. Autismo - Guia prático”. Brasília: CORDE (2003).
8. Mendes KDS., et al. “Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem”. Texto Contexto Enferm, Florianópolis 17.4 (2008): 758-764.
9. Moher D., et al. “The PRISMA Group (2009) Itens de relatório preferidos para revisões sistemáticas e meta-análises: a declaração PRISMA”. PLoS Medicine 7 (2009): e1000097.
10. Estes A., et al. “Long-Term Outcomes of Early Intervention in 6-Year-Old Children with Autism Spectrum Disorder”. Journal of the American Academy of Child and Adolescent Psychiatry 7 (2015): 580-587.
11. Adams JB., et al. “Comprehensive Nutritional and Dietary Intervention for Autism Spectrum Disorder-A Randomized, Controlled 12-Month Trial”. Nutrients 3 (2018): 369.
12. Sikich L., et al. “Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder”. The New England Journal of Medicine 385 (2021): 1462-1473.
13. Wood JJ., et al. “Cognitive Behavioral Treatments for Anxiety in Children with Autism Spectrum Disorder: A Randomized Clinical Trial”. JAMA Psychiatry 5 (2018): 474-483.
14. Singh K., et al. “Sulforaphane treatment of autism spectrum disorder (ASD)”. Proceedings of the National Academy of Sciences of the United States of America 43 (2014): 15550-15555.
15. Mazahery H., et al. “A Randomised Controlled Trial of Vitamin D and Omega-3 Long Chain Polyunsaturated Fatty Acids in the Treatment of Core Symptoms of Autism Spectrum Disorder in Children”. Journal of Autism and Developmental Disorders 5 (2019): 1778-1794.
16. Wieckowski AT., et al. “Early and Repeated Screening Detects Autism Spectrum Disorder”. The Journal of Pediatrics 234 (2022): 227-235.
17. Dawson G., et al. “Early behavioral intervention is associated with normalized brain activity in young children with autism”. Journal of the American Academy of Child and Adolescent Psychiatry 11 (2012): 1150-1159.
18. Crutel V., et al. “Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)”. Journal of Autism and Developmental Disorders 8 (2021): 2959-2972.
19. Jia W., et al. “Improvement of the health of people with autism spectrum disorder by exercise”. Revista Brasileira de Medicina do Esporte3 (2021): 282-285.
20. Brito AR., et al. “Effect of prednisolone on language function in children with autistic spectrum disorder: a randomized clinical trial”. Journal de Pediatric (Rio J) 1 (2021): 22-29.
21. Oliveira PLS., et al. “Terapia com base em integração sensorial em um caso de Transtorno do Espectro Autista com seletividade alimentar”. Cadernos Brasileiros de Terapia Ocupacional 30 (2022):
22. Montenegro ACA., et al. “Use of a robust alternative communication system in autism spectrum disorder: a case report”. Revista CEFAC2 (2022): e11421.
23. Lin J., et al. “Autism associated with 12q (12q24.31-q24.33) deletion: further report of an exceedingly rare disorder”. Einstein (São Paulo) 18 (2022):
24. Becker MM., et al. “Improvement of autism spectrum disorder symptoms in three children by using gastrin-releasing peptide”. The Journal of Pediatrics (Rio J) 92 (2016): 302-306.
25. Mergl M., et al. “Tipo de ecolalia em crianças com Transtorno do Espectro Autista”. Revista CEFAC6 (2015): 2072-2080.
26. Costa KTL., et al. “Percepção dos pais sobre hipersensibilidade auditiva de crianças com sinais clínicos de risco para o Transtorno do Espectro do Autismo”. Cadernos Brasileiros de Terapia Ocupacional 30 (2022):
27. Costa LLA., et al. “Psicodrama com crianças dentro do transtorno do espectro autista: uma experiência possível?” Revista Brasileira de Psicodrama 30 (2022):
28. Gomes KS., et al. “From social interaction to autonomy: ludic experiences in aquatic environment for children with autism spectrum disorder”. Journal of Physical Education 32 (2021):
29. Rocha CC., et al. “O perfil da população infantil com suspeita de diagnóstico de transtorno do espectro autista atendida por um Centro Especializado em Reabilitação de uma cidade do Sul do Brasil”. Revista de Saúde Coletiva 29.04 (2019): e290412.
30. Pesántez M., et al. “Utilización de Cannabidiol en un paciente pediátrico con trastorno del espectro autista y epilepsia: informe de un caso”. Revista Ecuatoriana de Pediatría1 (2021): 1-8.
31. Santos SC., et al. “Identificação de alterações genéticas relacionadas à síndrome do X frágil e ao transtorno de espectro do autismo por meio de ferramentas de bioinformática”. Revista De Ciências Médicas E Biológicas2 (2020): 292-297.

Citation

Citation: Laurindo Pereira de Souza., et al. “Impacts of Early Interventions in the Treatment of Autism Spectrum Disorder from a Medical Perspective". Acta Scientific Neurology 6.1 (2023): 12-22.

Copyright

Copyright: © 2023 Laurindo Pereira de Souza., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.